Provided by Tiger Fintech (Singapore) Pte. Ltd.

Terns Pharmaceuticals, Inc.

2.40
+0.16007.14%
Post-market: 2.450.0450+1.87%16:56 EDT
Volume:891.66K
Turnover:2.12M
Market Cap:209.51M
PE:-2.15
High:2.44
Open:2.23
Low:2.23
Close:2.24
Loading ...

Eli Lilly's stock soars as successful trial of weight-loss pill is a game changer

Dow Jones
·
17 Apr

Terns Pharmaceuticals (TERN) Gets a Buy from Mizuho Securities

TIPRANKS
·
15 Apr

Down -31.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Terns Pharmaceuticals (TERN)

Zacks
·
03 Apr

BRIEF-Terns Pharmaceuticals Reports Inducement Grant To New Employees Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
03 Apr

Terns Pharmaceuticals Reports Inducement Grant to New Employees Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
03 Apr

Promising Clinical Trials and Strong Financials Drive Buy Rating for Terns Pharmaceuticals

TIPRANKS
·
27 Mar

All You Need to Know About Terns Pharmaceuticals (TERN) Rating Upgrade to Buy

Zacks
·
27 Mar

Oppenheimer Remains a Buy on Terns Pharmaceuticals (TERN)

TIPRANKS
·
24 Mar

Terns Pharmaceuticals Reports 2024 Progress and Outlook

TIPRANKS
·
22 Mar

Terns Pharmaceuticals: Promising Investment with Strong Financials and Strategic Developments

TIPRANKS
·
22 Mar

Terns Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
21 Mar

Terns Pharmaceuticals reports Q4 EPS (24c), consensus (30c)

TIPRANKS
·
21 Mar

Terns Pharma Q4 2024 GAAP EPS $(0.24) Beats $(0.30) Estimate

Benzinga
·
21 Mar

BRIEF-Terns Pharmaceuticals Q4 Net Income USD -21.799 Million

Reuters
·
21 Mar

Terns Pharmaceuticals Q4 Pretax Profit USD -21.759 Million

THOMSON REUTERS
·
21 Mar

Terns Pharmaceuticals: Cash, Cash Equivalents & Marketable Securities of $358 Mln, Expected to Provide Runway Into 2028

THOMSON REUTERS
·
21 Mar

Press Release: Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates

Dow Jones
·
21 Mar

This Weight Loss Stock Could Skyrocket by 462%, According to Wall Street

Motley Fool
·
09 Mar

William Blair Initiates a Hold Rating on Terns Pharmaceuticals (TERN)

TIPRANKS
·
06 Mar

William Blair Initiates Terns Pharmaceuticals at Market Perform

MT Newswires Live
·
28 Feb